Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Schroder Investment Management Group
Schroder Investment Management Group lowered its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 1.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 206,070 shares of the biotechnology company’s stock after selling 2,490 shares during the quarter. Schroder Investment Management Group […]
More Stories
DOGE Says US National Science Foundation Canceling Over $325 Million in DEI Research
By Naveen Athrappully The National Science Foundation (NSF) has canceled hundreds of millions of dollars in diversity, equity, and inclusion...
Trump, Zelenskyy Meet One-on-One at Vatican Before Pope’s Funeral
By T.J. Muscaro U.S. President Donald Trump and Ukrainian President Volodymyr Zelenskyy held a brief one-on-one discussion inside St. Peter’s...
Saks Fifth Avenue to Close Store in San Francisco’s Union Square
By Jill McLaughlin Luxury department chain Saks Fifth Avenue confirmed April 25 that it will close its Union Square location...
Open Hip Joints to Avoid Knee Pain in Sitting Cross-Legged Positions
By Amber Yang Many people use meditation to relieve stress. However, if you choose to meditate while sitting in the...
Trump Says He Hopes Ukraine Will Immediately Sign Minerals Deal
By Tom Ozimek U.S. President Donald Trump said on Friday that Ukraine hasn’t signed a long-delayed rare earths agreement that...
Politicians and Pilgrims Alike Gather for Pope Francis’s Funeral
By T.J. Muscaro The sun rose high over a packed St. Peter’s Square on the morning of April 26 as...